Market reports, free public health charts and stories on immune health, across every category we cover.
Our markets on immune health, by category.
Worldwide reports first. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Worldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report OTC & NutraceuticalsWorldwide · 2024–2034
View report OTC & NutraceuticalsWorldwide · 2024–2034
View report OTC & NutraceuticalsWorldwide · 2024–2034
View report OTC & NutraceuticalsWorldwide · 2024–2034
View reportStories and field notes on immune health.
Seasonal flu causes about a billion cases a year. Vitamin C and zinc can shorten colds a little, but vaccines…
Read
Atopic dermatitis is the most common chronic skin condition, affecting about 225 million people, mostly…
ReadNamed as key players in the most of these markets.
AbbVie Inc.2 markets here
Bayer AG2 markets here
Pfizer Inc.2 markets here
Sanofi2 markets here
Teva Pharmaceutical Industries Ltd.2 markets here
Abbott1 market here
Abbott Laboratories1 market here
Airborne (Reckitt)1 market here
Allergan1 market here
Alticor Inc1 market here
AstraZeneca1 market here
Aurobindo Pharma1 market here
Each opens the market's statistics page, with every country we cover.
Healthcare Services
OTC & Nutraceuticals
Pharmaceuticals
Full reports carry researched sizes, forecasts and company profiles. We also build custom studies.
Acuitas market figures are supplied with each full report. Chart data comes from the public sources named on each chart.